A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
- 31 January 2018
- journal article
- review article
- Published by Elsevier BV in Urologic Oncology: Seminars and Original Investigations
- Vol. 36 (2), 43-53
- https://doi.org/10.1016/j.urolonc.2017.10.002
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder CancerEuropean Urology, 2012
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- Primary cT2 Bladder Cancer: A Good Candidate for Radiotherapy Combined with Cisplatin for Bladder PreservationJapanese Journal of Clinical Oncology, 2011
- Orthotopic Neobladder versus Ileal Conduit Urinary Diversion after Cystectomy – A Quality-of-Life Based ComparisonThe Annals of The Royal College of Surgeons of England, 2009
- Bladder Preservation Therapy Conducted by Intra-arterial Chemotherapy and Radiotherapy for Muscle Invasive Bladder CancerJapanese Journal of Clinical Oncology, 2009
- Bladder‐sparing, combined‐modality approach for muscle‐invasive bladder cancerCancer, 2007
- Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving TherapyJapanese Journal of Clinical Oncology, 2007
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapyCancer, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003